Hong Kong Journal of Nephrology
Volume 13, Issue 1 , Pages 5-18 , April 2011

Renal Disease in Hematological Malignancies

  • Ibrahiem Saeed Abdul-Rahman

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. Ibrahiem Saeed Abdul-Rahman, Department of Internal Medicine, King Fahd Hospital of the University, Dammam University, PO Box 40032, Al-Khobar 31952, Saudi Arabia

References 

  1. Olusanya AA , Huff G , Adeleye O , et al.   Primary renal non-Hodgkin's lymphoma presenting with acute renal failure . J NatI Med Assoc . 2003;95:220–224
  2. Troung LD , Soroka S , Seth AV , et al.   Primary lymphoma presenting as acute renal failure . Am J Kidney Dis . 1987;9:502–506
  3. Mills NE , Goldenberg AS , Liu D , et al.   B-cell lymphoma presenting as infiltrative renal disease . Am J Kidney Dis . 1992;19:181–184
  4. Malbrain ML , Lambercht GL , Daelemans R , et al.   Acute renal failure due to bilateral lymphomatous infiltrates: primary extranodal non-Hodgkin's lymphoma (p-EN-NHL) of the kidneys: does it really exist? . Clin Nephrol . 1994;42:163–169
  5. Kandel LB , McCullough DL , Harrison LH , et al.   Primary renal lymphoma: does it exist? . Cancer . 1987;60:386–391
  6. Stallone G , Infante B , Manno C , et al.   Primary renal lymphoma does exist: case report and review of literature . J Nephrol . 2000;13:367–372
  7. Choi JH , Choi GB , Shim KN , et al.   Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy . Acta Haematol . 1997;97:231–235
  8. Yasunaga Y , Hoshida Y , Hashimoto M , et al.   Malignant lymphoma of the kidney . J Surg Oncol . 1997;64:207–211
  9. Rajappa S , Digumarti R , Immaneni SR , et al.   Primary renal lymphoma presenting with paraneoplastic limbic encephalitis . J Clin Oncol . 2007;25:3783–3785
  10. Markert A , May A , Weber J , et al.   Bilateral renal lymphoma after paraneoplastic limbic encephalitis . J Clin Oncol . 2009;27:1142–1144
  11. Berard RJ , Thompson C , Verani R , et al.   Lymphoma presenting as acute renal failure . Am J Med . 1988;84:366–367
  12. JP Brouland , F Meeus , J Rossert , et al.   Primary bilateral B-cell renal lymphoma: a case report and review of the literature . Am J Kidney Dis . 1994;24:586–589
  13. Ferry JA , Harris NL , Papanicolaou N , et al.   Lymphoma of the kidney: a report of 11 cases . Am J Surg Pathol . 1995;19:134–144
  14. Miyaki JS , Fitterer S , Houghton DC . Diagnosis and characterization of non-Hodgkin's lymphoma in a patient with acute renal failure . Am J Kidney Dis . 1990;16:262–263
  15. Poulis C . Primary renal non-Hodgkin's lymphoma . Scand J Urol Nephrol . 1990;24:227–230
  16. Dobkin SF , Brem AS , Caldmone AA . Primary renal lymphoma . J Urol . 1991;146:1588–1590
  17. Harris GJ , Lager DJ . Primary renal lymphoma . J Surg Oncol . 1991;46:263–277
  18. Vandermolen LA , Dillman RO . Primary lymphoma of the kidney: complete remission after systemic chemotherapy . J Natl Cancer Inst . 1993;85:505–506
  19. Bertoncelli C , Airoldi G , Zigrossi P , et al.   Parenchymal renal involvement in three cases of non-Hodgkin's lymphoma: clinical and pathological features . Haematologica . 1993;78:58–60
  20. Tsang K , Kneafsey P , Gill MJ . Primary lymphoma of the kidney in the acquired immunodeficiency syndrome . Arch Pathol Laby Med . 1993;117:541–543
  21. Okuno SH , Hoyer JD , Ristow K , et al.   Primary renal non-Hodgkin's lymphoma: an unusual extranodal site . Cancer . 1995;75:2258–2261
  22. Glicklich J , Hakenberg OW , Naumann R , et al.   Primary renal non-Hodgkin's lymphoma, a difficult diagnosis . Onkologie . 2002;25:273–277
  23. Ladha A , Haider G . Primary renal lymphoma . J Coll Physicians Surg Pak . 2008;18:584–585
  24. Tefekli A , Baykal M , Binbay M , et al.   Lymphoma of the kidney: primary or initial manifestation of rapidly progressive disease? . Int Urol Nephrol . 2006;38:775–778
  25. Porocaro AB , D'Amico A , Novella G , et al.   Primary lymphoma of the kidney: report of a case and update of the literature . Arch Ital Urol Androl . 2002;74:44–47
  26. Olusanya A , Gregory H , Olufemi A , et al.   Primary renal lymphoma presenting with acute renal failure . J Nat Med Assoc . 2003;95:220–224
  27. Richards MA , Mootoosamy I , Reznek RH , et al.   Renal involvement in patients with non-Hodgkin's lymphoma: clinical and pathological features in 23 cases . Hematol Oncol . 1990;8:105–110
  28. Chamsangavej C . Lymphoma of the genitourinary tract . Radiol Clin North Am . 1990;28:865–877
  29. Obrador GT , Price B , O'Meara Y , et al.   Acute renal failure due to lymphomatous infiltration of the kidneys . J Am Soc Nephrol . 1997;8:1348–1354
  30. Nishikawa K , Sekiyama S , Suzuki T , et al.   A case of angiotropic large cell lymphoma manifesting nephrotic syndrome and treated successfully with combination chemotherapy . Nephron . 1991;58:479–482
  31. Agar JWM , Gates PC , Vaughan SL . Renal biopsy in angiotropic large cell lymphoma . Am J Kidney Dis . 1994;24:92–96
  32. Poderly W , Cantwell B , Penelly J , et al.   Renal glomerulopathies associated with Hodgkin's disease . Cancer . 1985;56:874–875
  33. Dabbs DJ , Morel-Maroger L , Mignon F , et al.   Glomerular lesions in lymphoma and leukemias . Am J Med . 1986;80:63–70
  34. Moulin B , Ronco PM , Mougenot B , et al.   Glomerulonephritis in chronic lymphocytic leukemia and related-B-cell lymphomas . Kidney Int . 1992;42:127–135
  35. Rosas SE , Tomaszewski JE , Feldman HI , et al.   Membranoproliferative glomerulonephritis type I, mixed cryoglobulinemia and lymphoma in the absence of hepatitis C infection . Am J Nephrol . 1999;19:599–604
  36. Strokes MB , Wood B , Alpers CE . Membranoproliferative glomerulonephritis associated with low-grade B-cell lymphoma presenting in the kidney . Clin Nephrol . 2002;57:303–309
  37. Tornroth T , Heiro M , Marcussen N , Franssila K . Lymphomas diagnosed by percutaneous kidney biopsy . Am J Kidney Dis . 2003;42:960–971
  38. Alshayeb H , Wall BM . Non Hodgkin's lymphoma associated membranoproliferative glomerulonephritis: rare case of long term remission with chemotherapy-a case report . Cases J . 2009;2:201–204
  39. Audard V , Larousserie F , Grimbert P , et al.   Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: a report of 21 cases and review of literature . Kidney Int . 2006;69:2251–2260
  40. Korzets Z , Golan E , Monor Y , et al.   Spontaneously remitting minimal change nephropathy preceding a relapse of Hodgkin's disease by 19 months . Clin Nephrol . 1992;38:125–127
  41. Lanore JJ , Brunet F , Pochard F , et al.   Hemodialysis for acute renal failure in patients with hematologic malignancies . Crit Care Med . 1991;19:346–351
  42. Vardiman JW , Pierre R , Thiele J . Chronic myelogenous leukemia . In:  ES Jaffe ,  NL Harris ,  H Stein , et al. editor. Tumors of Haematopoietic and Lymphoid Tissues . Washington, DC: IARC Press; 2001;p. 20–26
  43. Xiao JC , Walz-Mattmuller R , Ruck P , et al.   Renal involvement in myeloproliferative and lymphoproliferative disorders: a study of autopsy cases . Gen Diagn Pathol . 1997;142:147–153
  44. Kanno Y , Sakuyama M , Niitsu H , et al.   Renal and electrolyte disturbances in chronic myelogenous leukemia . Rinsho Ketsueki . 1992;33:1128–1135
  45. Talwar R , Dash SC , Kucheria K , et al.   A case of chronic myeloid leukemia complicated with minimal change nephrotic syndrome . Acta Haematol . 2003;109:101–103
  46. Springate JE , Brecher M , Brentjens J , et al.   Glomerulonephritis and chronic myelogenous leukemia . Child Nephrol Urol . 1988;89:298–300
  47. Morschhauser F , Wattel E , Pagniez D , et al.   Glomerular injury in chronic myelo-monocytic leukemia . Leuk Lymphoma . 1995;18:479–483
  48. Lieutaud T , Mejean A , Prayssac P , et al.   Renal and adrenal gland localization of chronic myelo-monocytic leukemia presenting as a kidney tumor . Leuk Lymphoma . 1999;34:405–408
  49. Bane AL , Enright H , Sweeney EC . Chronic myelo-monocytic leukemia revealed by uncontrollable hematuria . Arch Pathol Lab Med . 2001;125:657–659
  50. Robinson GT , Sundaram KR , Dilly SA , et al.   Renal failure in a patient with chronic myelo-monocytic leukemia . Nephrol Dial Transplant . 1997;12:1500–1502
  51. Philips JK , Bass PS , Majumdar G , et al.   Renal failure caused by leukemic infiltration in chronic lymphocytic leukemia . J Clin Pathol . 1993;46:1131–1133
  52. Kirshbaum JD , Preuss FS . Leukemia: a clinical and pathological study of one hundred and twenty-three fatal cases in a series of 14,400 necropsies . Arch Intern Med . 1993;71:777–792
  53. Schwartz JB , Samsuddin AM . The effects of leukemic infiltrates in various organs in chronic lymphocytic leukemia . Hum Pathol . 1981;12:432–440
  54. Barcos M , Lane W , Gomez GA , et al.   An autopsy study of 1206 acute and chronic leukemia . Cancer . 1987;60:827–837
  55. Saggi S , Calandri C , Muhlfeldr T , et al.   Renal failure due to leukemic infiltration in chronic lymphocytic leukemia: case report . Nephrol Dial Transplant . 1990;5:1051–1052
  56. Tucker B , Brown AL , D'Ardenne AJ , et al.   Reversible renal failure due to renal infiltration and associated tubulointerstitial disease in chronic lymphocytic leukemia . Nephrol Dial Transplant . 1990;5:616–618
  57. Moulin B , Ronco PM , Mougenot B , et al.   Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas . Kidney Int . 1992;42:127–135
  58. Eisterer W , Neyer U , Hilbe W , et al.   Effect of cyclosporine A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia . Nephron . 1996;72:468–471
  59. Butty H , Asfoura J , Cortese F , et al.   Chronic lymphocytic leukemia-associated membranous glomerulopathy: remission with fludarabine . Am J Kidney Dis . 1999;33:E8
  60. N Da'as , A Polliac , Y Cohen , et al.   Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients . Eur J Haematol . 2001;67:158–164
  61. Touchard G , Perud'Homme JL , Aucouturier P , et al.   Nephrotic syndrome associated with chronic lymphocytic leukemia: an immunological and pathological study . Clin Nephrol . 1989;31:107–116
  62. Blade J , Kyle RA , Greipp PR . Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years . Br J Haematol . 1996;93:345–351
  63. V Eleutherakis-Papaiakovou , A Bamis , D Gika , et al.   Renal failure in multiple myeloma: incidence, correlation and diagnostic significance . Leuk Lymphoma . 2007;48:337–341
  64. Goldschmidt H , Lannert H , Bommer J , et al.   Multiple myeloma and renal failure . Nephrol Dial Transplant . 2000;15:301–305
  65. Blade J , Fernandez-LIama P , Bosch F , et al.   Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution . Arch Intern Med . 1998;158:1889–1894
  66. Buxbaum JN , Chuba JV , Hellman GC , et al.   Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis: clinical features, immunopathology and molecular analysis . Ann Intern Med . 1990;112:455–460
  67. Sanders PW . Dysproteinemias and amyloidosis . In:  A Greenberg editors. Primer on Kidney Diseases . 2nd edition. London: Academic Press; 1998;p. 220–221
  68. Appel GB , Radhakrishnan J , V D'Agati . Secondary glomerular disease: light chain deposition disease . In:  BM Brenner editors. Brenner and Rectors: The Kidney . 8th ed. Philadelphia: Saunders Elsevier; 2004;p. 1106–1107
  69. Pozzi C , D'Amico M , Fogazzi GB , et al.   Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors . Am J Kidney Dis . 2003;42:1154–1163
  70. Leung N , Lager DJ , Gertz MA , et al.   Long-term outcome of renal transplantation in light-chain deposition disease . Am J Kidney Dis . 2004;43:147–153
  71. Chauveau D , Chaukroun G . Bence Jones proteinuria and myeloma kidney . Nephrol Dial Transplant . 1996;11:413–415
  72. Sanders PW , Booker BB . Pathobiology of cast nephropathy from human Bence Jones proteins . J Clin Invest . 1992;89:630–635
  73. Goldschmidt H , Lannert H , Boomer J , et al.   Renal failure in multiple myeloma “the myeloma kidney”: state of the art . Saudi J Kidney Dis Transplant . 2001;12:145–150
  74. Winearls GG . Acute myeloma kidney . Kidney Int . 1995;48:1347–1351
  75. Lameire N , Van-Biesen W , Vanholder R , et al.   Acute renal failure . Lancet . 2005;365:417–430
  76. Batuman V . Proximal tubular injury in myeloma . Contrib Nephrol . 2007;153:87–104
  77. Decourt C , Rocca A , Bridoux F , et al.   Multinational analysis in murine models for myeloma-associated Fanconi's syndrome or cast nephropathy . Blood . 1999;94:3559–3566
  78. Somlens P , Barnes JL , Kreisberg R . Hypercalcemia can potentiate the nephrotoxicity of Bence Jones proteins . J Lab Clin Med . 1987;110:460–463
  79. CS McCarthy , JA Becker . Multiple myeloma and contrast media . Radiology . 1992;183:519–525
  80. Tepel M , Giet MVD , Schwarzfeld C , et al.   Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine . N Engl J Med . 2000;343:180–184
  81. Kyle RA , Certz MA , Witzig TE , et al.   Review of 1027 patients with newly diagnosed multiple myeloma . Mayo Clin Proc . 2003;78:21–33
  82. Kyle RA , Remstein ED , Therneau TM , et al.   Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma . N Engl J Med . 2007;356:2582–2590
  83. He Y , Wheatley K , Clark O , et al.   Early versus deferred treatment for early stage multiple myeloma . Cochrane Database Syst Rev . 2003;CD004023
  84. Dimopoulos MA , Moulopoulos A , Smith T , et al.   Risk of disease progression in asymptomatic multiple myeloma . Am J Med . 1993;94:57–61
  85. Kyle RA , Rajkumar SV . Multiple myeloma . Blood . 2008;111:2962–2972
  86. Kyle RA , Rajkumar SV . Multiple myeloma . N Engl J Med . 2004;351:1860–1873
  87. San Miguel JF . Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma . N Engl J Med . 2008;359:906–917
  88. Durie BGM . Treatment of myeloma: are we making progress? . N Engl J Med . 2008;359:964–966
  89. Zonder JA , Crowley J , Hussein MA , et al.   Superiority of lenalidomide (Len) plus high-dose dexamethasone (HD) compared to HD alone as treatment of newly-diagnosed multiple myeloma (NDMM): results of randomized, double-blinded, placebo-controlled SWOG trial . Blood . 2007;110:32a; [abstract 77].
  90. Rajkumar SV , Jacobus S , Callander N , et al.   Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomized controlled trial . Lancet Oncol . 2010;11:29–37
  91. Facon T , Mary JY , Hulin C , et al.   Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced intensity autologous stem cell transplantation in elderly patients with multiple myeloma: a randomized trial . Lancet . 2007;370:1209–1218
  92. Palumbo A , Falco P , Falcone A , et al.   Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results . Clin Lymphoma Myeloma . 2009;9:145–150
  93. Hulin C , Facon T , Rodon P , et al.   Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma . J Clin Oncol . 2009;27:3664–3670
  94. Mateos MV , Hernandez JM , Hernandez MT , et al.   Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of multicenter phase I/II study . Blood . 2006;108:2165–2172
  95. Berenson JR , Lichtenstein A , Porter L , et al.   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma: Myeloma Aredia Study Group . N Engl J Med . 1996;334:488–493
  96. Kyle RA , Yee GC , Somerfield MR , et al.   American Society of Clinical Oncology 2007: clinical practice guideline update on the role of bisphosphonates in multiple myeloma . J Clin Oncol . 2007;25:2464–2472
  97. Wang EP , Kaban LB , Strewler GJ , et al.   Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphospphonate therapy . J Oral Maxillofac Surg . 2007;65:1328–1331
  98. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma: National Guideline Clearinghouse . Available at http://www.guideline.gov/summary.aspx?docid=10857&nbr=005670 Accessed May 1, 2009.
  99. Benguin Y . Erythropoiesis and erythropoietin in multiple myeloma . Leuk Lymphoma . 1995;18:413–421
  100. Mikhael J , Melosky B , Cripps C , et al.   Canadian supportive care recommendations for the management of anemia in patients with cancer . Curr Oncol . 2007;14:209–217
  101. Baz R , Walker E , Cohoueiri TK , et al.   Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma . Acta Haematol . 2007;117:162–167
  102. Ludwig H , Drach J , Graf H , et al.   Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma . Haematologica . 2007;92:1411–1414
  103. Vickrey E , Allen S , Mehta J , et al.   Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy . Cancer . 2009;115:229–232
  104. IS Abdul-Rahman . A prospective study of renal failure in multiple myeloma: a promising role for plasmapheresis . Haema . 2003;6:358–365
  105. Johnson WJ , Kyle RA , Pineda AA , et al.   Treatment of renal failure associated with multiple myeloma . Arch Intern Med . 1990;150:863–869
  106. Clark WF , Stewart AK , Rock GA , et al.   Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial . Ann Intern Med . 2005;143:777–784
  107. Ritz E . Plasma exchange for acute renal failure of multiple myeloma: logical yet ineffective . J Am Soc Nephrol . 2006;17:914–916
  108. Cserti C , Haspel R , Stowell C , et al.   Light-chain removal by plasmapheresis in myeloma-associated renal failure . Transfusion . 2007;47:511–514
  109. Evans N , Hattersley J , Hutchinson C , et al.   Modelling of hemodialysis in limiting serum free light-chains in patients with renal failure . In:  DD Feng ,  J Zaytoon editor. Proceedings of the 6th IFAC Symposium on Modelling and Control in Biomedical Systems . Oxford: Elsevier; 2006;p. 75–80
  110. Leung N , Gertz MA , Zeldenrust SR , et al.   Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains . Kidney Int . 2008;73:1282–1288
  111. Hutchison CA , Bradwell AR , Cook M , et al.   Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis . Clin J Am Soc Nephrol . 2009;4:745–754
  112. Basnayake K , Hutchison C , Kamel D , et al.   Resolution of cast nephropathy following free light chain removal by hemodialysis in a patient with multiple myeloma: a case report . J Med Case Rep . 2008;2:380–385
  113. Davidson MB , Thakkar S , Hix JK , et al.   Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome . Am J Med . 2004;116:546–554
  114. Jones DP , Mahmoud H , Chesney RW . Tumor lysis syndrome: pathogenesis and management . Pediatr Nephrol . 1995;9:206–212
  115. Flombaum CD . Metabolic emergencies in the cancer patients . Semin Oncol . 2000;27:322–334
  116. Fassas AB , Desikan KR , Siegel D , et al.   Tumor lysis syndrome complicating high-dose treatment in patients with multiple myeloma . Br J Haematol . 1999;105:938–941
  117. Backsgaard I , Sorenson JB . Acute tumor lysis syndrome in solid tumors: a case report and review of the literature . Cancer Chemother Pharmacol . 2003;51:187–192
  118. Richardson P , Hideshima T , Anderson KC . Multiple myeloma and related disorders . In:  MD Abeloff ,  JO Armitag ,  JE Niederhuber , et al. editor. Clinical Oncology . 3rd edition. Philadelphia: Elsevier Churchill Livingstone; 2004;p. 2970–2971
  119. Terpos E , Politou M , Rahemtulla A . Tumor lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration . J Cancer Res Clin Oncol . 2004;130:623–625
  120. Bickert B , Reilly A . Pediatric tumor lysis syndrome . J Pharm Pract . 2004;17:447–454
  121. Arrambide K , Toto RD . Tumor lysis syndrome . Semin Nephrol . 1993;13:273–280
  122. Coiffier B , Altman A , Pui CH , et al.   Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review . J Clin Oncol . 2008;26:2767–2778
  123. Sallan S . Management of acute tumor lysis syndrome . Semin Oncol . 2001;28(Suppl 5):9–12
  124. Rampello E , Fricia T , Malaguarnera M . The management of tumor lysis syndrome . Nat Clin Pract Oncol . 2006;8:438–447
  125. Balint E , Marshall CF , Sprague SM . Effects of the vitamin D analogues paricalcitol and calcitonin . Am J Kidney Dis . 2000;36:789–796
  126. Singer GG , Brenner BM . Fluid and electrolyte disturbances . In:  E Braunwald ,  AS Fauci ,  DL Kasper , et al. editor. Harrison's Principles of Internal Medicine . 15th edition. New York: McGraw-Hill; 2001;p. 271–283
  127. Pui CH , Relling MV , Lascombes F , et al.   Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies . Leukemia . 1997;11:1813–1816
  128. Ueng S . Rasburicase (Elitek): a novel agent for tumor lysis syndrome . BUMC Proc . 2005;18:275–279
  129. Coiffier B , Mounier N , Bologna S , et al.   Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Group d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study . J Clin Oncol . 2003;21:4402–4406
  130. Cairo MS , Bishop M . Tumor lysis syndrome: new therapeutic strategies and classification . Br J Haematol . 2004;127:3–11
  131. Pui CH , Mahmoud HH , Wiley JM , et al.   Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma . J Clin Oncol . 2001;19:697–704
  132. Goldman SC , Holcenberg JS , Finklestein JZ , et al.   A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis . Blood . 2001;97:2998–3003
  133. Kersting S , Koomans HA , Hene RJ , et al.   Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival . Bone Marrow Transplant . 2007;39:359–365
  134. Hingorani SR , Guthrie K , Batchelder A , et al.   Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors . Kidney Int . 2005;67:272–277
  135. Moak JL , Byrnes JJ . Thrombotic microangiopathies associated with drugs and bone marrow transplantation . Hematol Oncol Clin North Am . 1996;10:485–497
  136. George JN , Li X , McMinn JR , et al.   Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma . Transfusion . 2004;44:294–304
  137. Miralbell R , Dieri S , Mermillod B , et al.   Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease . J Clin Oncol . 1996;14:579–585
  138. Cohen EP , Lawton CA , Moulder JE , et al.   Clinical course of late-onset bone marrow transplant nephropathy . Nephron . 1993;64:626–634
  139. Cohen EP , Lawton CA , Moulder JE , et al.   Bone marrow transplant nephropathy: radiation nephritis revisited . Nephron . 1995;70:217–222
  140. Zenz T , Schlenk RF , Glatting G , et al.   Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation . J Nucl Med . 2006;47:278–286
  141. Van Why SK , AL Friedman , LJ Wei , et al.   Renal insufficiency after bone marrow transplantation in children . Bone Marrow Transplant . 1991;7:383–388
  142. Parikh CR , McSweeney PA , Korulas D , et al.   Renal dysfunction in allogeneic hematopoietic cell transplantation . Kidney Int . 2002;62:566–573
  143. Cruz DN , Perazella MA , Mahnensmith RL . Bone marrow transplant nephropathy: a case report and review of literature . J Am Soc Nephrol . 1997;8:166–173
  144. Ishizuka Y , Yokota A , Hara S , et al.   Transient nephrotic syndrome after allogeneic bone marrow transplantation for chronic myelogenous leukemia . Jpn J Clin Hematol . 2001;42:321–327
  145. Rossi L , Gardarelli F , Vampa ML , et al.   Membranous glomerulo-nephritis after hematopoietic cell transplantation for multiple myeloma . Nephron . 2001;88:260–263
  146. Chien YH , Lin KH , Lee TY , et al.   Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease . J Formos Med Assoc . 2000;99:503–506
  147. Ohsawa I , Ohi H , Fujita T , et al.   Glomerular and extraglomerular immune complex deposits in a bone marrow transplant recipient . Am J Kidney Dis . 2000;36:E3
  148. Kimura S , Horei A , Hiki Y , et al.   Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma . Blood . 2003;101:4219–4221
  149. Silva VA , Frei-lahr D , Brown RA , et al.   Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation . J Clin Apheresis . 1991;6:16–20
  150. Li C , Lim SW , Sun BK , et al.   Chronic cyclosporine nephrotoxicity: new insights and preventive strategies . Yonsei Med J . 2004;45:1004–1016
  151. Lawton CA , Cohen EP , Murray KJ , et al.   Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation . Bone Marrow Transplant . 1997;20:1069–1074
  152. Tarbell NJ , Guinan EC , Chin L , et al.   Renal insufficiency after total body irradiation for pediatric bone marrow transplantation . Radiother Oncol . 1990;18(Suppl 1):139–142
  153. Cohen EP . Radiation nephropathy after bone marrow transplantation . Kidney Int . 2000;58:903–918
  154. Lawton C , Fish BL , Moulder JE . Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantation . Int J Radiat Oncol Biol Phys . 1994;28:883–889
  155. Sayegh MH , Milford EL , Fine NA , et al.   Immunologic tolerance to renal allografts after bone marrow transplants from the same donors . Ann Intern Med . 1991;114:954–955
  156. Scandling JD , Busque S , Dejbakhsh-Jones S , et al.   Tolerance and chimerism after renal and hematopoietic-cell transplantation . N Engl J Med . 2008;358:362–368

PII: S1561-5413(11)60002-1

doi: 10.1016/S1561-5413(11)60002-1

Hong Kong Journal of Nephrology
Volume 13, Issue 1 , Pages 5-18 , April 2011

Article Tools